Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group.
Ka K, Schiappa R, Terlizzi M, Mallet F, Martin E, Chand ME, Demogeot N, Peiffert D, Pommier P, Quivrin M, Kissel M, Pasquier C, Khalifa J, Bossi A, Hannoun-Levi JM, Blanchard P. Ka K, et al. Among authors: khalifa j. Radiother Oncol. 2023 Mar;180:109460. doi: 10.1016/j.radonc.2022.109460. Epub 2023 Jan 10. Radiother Oncol. 2023. PMID: 36638842
Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder.
Khalifa J, Supiot S, Pignot G, Hennequin C, Blanchard P, Pasquier D, Magné N, de Crevoisier R, Graff-Cailleaud P, Riou O, Cabaillé M, Azria D, Latorzeff I, Créhange G, Chapet O, Rouprêt M, Belhomme S, Mejean A, Culine S, Sargos P. Khalifa J, et al. Radiother Oncol. 2021 Aug;161:95-114. doi: 10.1016/j.radonc.2021.06.011. Epub 2021 Jun 10. Radiother Oncol. 2021. PMID: 34118357 Review.
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study.
Masson I, Bellanger M, Perrocheau G, Mahé MA, Azria D, Pommier P, Mesgouez-Nebout N, Giraud P, Peiffert D, Chauvet B, Dudouet P, Salem N, Noël G, Khalifa J, Latorzeff I, Guérin-Charbonnel C, Supiot S. Masson I, et al. Among authors: khalifa j. Front Oncol. 2022 Jan 11;11:781121. doi: 10.3389/fonc.2021.781121. eCollection 2021. Front Oncol. 2022. PMID: 35087753 Free PMC article.
Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer.
Levy A, Khalifa J, Martin E, Botticella A, Quevrin C, Lavaud P, Aldea M, Besse B, Planchard D, Barlesi F, Deutsch E, Massabeau C, Doyen J, Le Péchoux C. Levy A, et al. Among authors: khalifa j. Clin Transl Radiat Oncol. 2023 May 3;41:100637. doi: 10.1016/j.ctro.2023.100637. eCollection 2023 Jul. Clin Transl Radiat Oncol. 2023. PMID: 37206411 Free PMC article.
The role of radiation therapy for de novo metastatic bladder and renal cancers.
Sargos P, Le Guevelou J, Khalifa J, Albiges L, Azria D, de Crevoisier R, Supiot S, Créhange G, Roubaud G, Chapet O, Pasquier D, Blanchard P, Latorzeff I. Sargos P, et al. Among authors: khalifa j. Cancer Radiother. 2024 Feb;28(1):56-65. doi: 10.1016/j.canrad.2023.02.004. Epub 2023 Jun 5. Cancer Radiother. 2024. PMID: 37286452 Review.
Impact of radiation on host immune system in patients treated with chemoradiotherapy and durvalumab consolidation for unresectable locally advanced non-small cell lung cancer.
Pasquier C, Chaltiel L, Massabeau C, Rabeau A, Lebas L, Lusque A, Texier JS, Moyal EC, Mazières J, Khalifa J. Pasquier C, et al. Among authors: khalifa j. Front Oncol. 2023 Jun 16;13:1186479. doi: 10.3389/fonc.2023.1186479. eCollection 2023. Front Oncol. 2023. PMID: 37397359 Free PMC article.
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer.
Khalifa J, Thébault N, Scarlata CM, Norkowski E, Massabeau C, Brouchet L, Peries Bataille S, Casaroli C, Vaz L, Valle C, Sarot E, Saint-Laurent N, Martin E, Pages PB, Millière A, Mazières J, Cohen-Jonathan Moyal E, Lauzéral-Vizcaïno F, Ayyoub M. Khalifa J, et al. Front Oncol. 2023 Nov 22;13:1269166. doi: 10.3389/fonc.2023.1269166. eCollection 2023. Front Oncol. 2023. PMID: 38074683 Free PMC article.
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Masson I, Larriviere L, Mahé MA, Azria D, Pommier P, Mesgouez-Nebout N, Giraud P, Peiffert D, Chauvet B, Dudouet P, Salem N, Noël G, Khalifa J, Latorzeff I, Guérin-Charbonnel C, Supiot S. Masson I, et al. Among authors: khalifa j. Clin Transl Radiat Oncol. 2023 Nov 17;44:100702. doi: 10.1016/j.ctro.2023.100702. eCollection 2024 Jan. Clin Transl Radiat Oncol. 2023. PMID: 38111609 Free PMC article.
69 results